SECsense Logo

Cero Therapeutics 8-K Report: Key Stock Insights & Financial Data

$CERO
Form 8-K
Filed on: 2025-01-10
Source
Cero Therapeutics 8-K Report: Key Stock Insights & Financial Data

Based on the provided section of the financial report for Cero Therapeutics Holdings, Inc., here are the key insights and important information extracted:

  1. Company Information:
  • Name: Cero Therapeutics Holdings, Inc.
  • CIK Number: 0001870404
  • Address: 201 Haskins Way, Suite 230, South San Francisco, CA 94080
  • Contact Number: 650-407-2376
  1. Filing Type:
  • This is an 8-K form, which indicates a current report filed with the SEC.
  1. Filing Date:
  • The report is dated January 6, 2025.
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001 per share.
  • Warrants:
    • Each whole warrant is exercisable for one share of common stock.
  1. Market Listing:
  • The company's common stock and warrants are traded on NASDAQ under the ticker symbols "CERO" for common stock and "CEROW" for warrants.
  1. Units of Measurement:
  • The financial data is presented in U.S. Dollars (USD) and shares.
  1. Contextual Metadata:
  • The report specifies the financial data pertains to a single date, January 6, 2025, suggesting that the report may contain information on events or transactions as of that date.

Summary

Cero Therapeutics Holdings, Inc. filed an 8-K report on January 6, 2025, detailing its common stock with a par value of $0.0001 and corresponding warrants, each allowing the purchase of one share of common stock. The company is listed on NASDAQ with ticker symbols CERO and CEROW for its stock and warrants, respectively. The report includes essential information regarding the company's identification and contact details.